NantKwest Inc (NASDAQ:NK)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - NK

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - NK

  • Market Cap$933.940m
  • SymbolNASDAQ:NK
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS63016Q1022

Company Profile

NantKwest Inc is a United States-based firm functioning in the healthcare sector. It is focused on providing immunotherapeutic agents, especially natural killer cells to treat cancer, infectious and inflammatory diseases. Natural Killer (NK) cells are ancient cells in the human body designed to recognize and detect cells under stress or infected. The company's drug candidates such as activated NK cells, high-affinity NKs and target activated NK's address virally-induced cancers, viral, fungal and bacterial infections as well as critical diseases such as Ebola. Its pipeline product includes taNK, haNK, and aNK. Most of NatWest's sales are concentrated in the United States region although it has a reasonable market in Europe and other Non-U.S. territories.NantKwest Inc is a biotechnology firm operating mainly in the United States. It undertakes research and discovery of drugs to cure virally-induced cancers, bacterial and fungal diseases. Its pipeline product includes taNK, haNK, and aNK.

Latest NK news

Currently there for this company. Visit our news hub for other news .